JP2000516610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000516610A5 JP2000516610A5 JP1998509841A JP50984198A JP2000516610A5 JP 2000516610 A5 JP2000516610 A5 JP 2000516610A5 JP 1998509841 A JP1998509841 A JP 1998509841A JP 50984198 A JP50984198 A JP 50984198A JP 2000516610 A5 JP2000516610 A5 JP 2000516610A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2328696P | 1996-08-16 | 1996-08-16 | |
| US60/023,286 | 1996-08-16 | ||
| PCT/US1997/013816 WO1998006380A2 (en) | 1996-08-16 | 1997-08-08 | Dosage form for providing ascending dose of drug |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000516610A JP2000516610A (ja) | 2000-12-12 |
| JP2000516610A5 true JP2000516610A5 (show.php) | 2005-04-07 |
| JP4393587B2 JP4393587B2 (ja) | 2010-01-06 |
Family
ID=21814183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50984198A Expired - Lifetime JP4393587B2 (ja) | 1996-08-16 | 1997-08-08 | 医薬の上昇性投与量を提供するための薬剤投与型 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0957899B1 (show.php) |
| JP (1) | JP4393587B2 (show.php) |
| CN (2) | CN101518517B (show.php) |
| AT (1) | ATE234602T1 (show.php) |
| AU (1) | AU3909597A (show.php) |
| CA (1) | CA2263558A1 (show.php) |
| CY (1) | CY2475B1 (show.php) |
| DE (1) | DE69720055T2 (show.php) |
| DK (1) | DK0957899T3 (show.php) |
| ES (1) | ES2194210T3 (show.php) |
| PT (1) | PT957899E (show.php) |
| WO (1) | WO1998006380A2 (show.php) |
| ZA (1) | ZA977254B (show.php) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| JP4714313B2 (ja) * | 1996-09-30 | 2011-06-29 | アルザ コーポレイション | 剤形および薬剤の投与法 |
| EP1690531A3 (en) * | 1996-09-30 | 2010-01-20 | Alza Corporation | Dosage form and method for administering drug |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| DK0946151T3 (da) * | 1996-11-25 | 2006-08-28 | Alza Corp | Doseringsform med stigende dosisfrigivelse |
| US6962997B1 (en) | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
| AU2012232984B2 (en) * | 1998-06-03 | 2015-10-29 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| KR100890537B1 (ko) * | 1998-06-03 | 2009-03-27 | 알자 코포레이션 | 연장된 약물 치료를 제공하기 위한 방법 및 장치 |
| AU2004200938B2 (en) * | 1998-06-03 | 2006-09-14 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| JP2002516848A (ja) * | 1998-06-03 | 2002-06-11 | アルザ・コーポレーション | 長時間の薬物療法を与える方法および装置 |
| KR100827254B1 (ko) * | 1998-06-03 | 2008-05-07 | 알자 코포레이션 | 연장된 약물 치료를 제공하기 위한 방법 및 장치 |
| EP2020229A1 (en) | 1998-11-02 | 2009-02-04 | Elan Pharma International Limited | Multiparticulate modified release composition |
| US6419960B1 (en) | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
| JP2002541093A (ja) | 1999-04-06 | 2002-12-03 | ファーマクエスト・リミテッド | ｄ−ｔｈｒｅｏ−メチルフェニデートおよび第２のＣＮＳ刺激薬のパルス性送達のための薬学的投薬形態 |
| CA2395974A1 (en) * | 2000-01-20 | 2001-07-26 | Suggy S. Chrai | Multi-step drug dosage forms |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| CN1684670A (zh) * | 2002-07-29 | 2005-10-19 | 阿尔扎公司 | 用于控制释放帕潘立酮的方法和剂型 |
| AR041744A1 (es) * | 2002-10-31 | 2005-05-26 | Alza Corp | Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida |
| US7988993B2 (en) | 2002-12-09 | 2011-08-02 | Andrx Pharmaceuticals, Inc. | Oral controlled release dosage form |
| EP2184058B1 (en) | 2003-09-26 | 2012-02-08 | ALZA Corporation | Drug coating providing high drug loading and methods for providing the same |
| MXPA06003452A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente. |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| PL116330U1 (en) | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
| JP2011511782A (ja) | 2008-02-12 | 2011-04-14 | アボット・ラボラトリーズ | 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途 |
| WO2015001488A1 (en) | 2013-07-01 | 2015-01-08 | Ranbaxy Laboratories Limited | Extended-release tablets of paliperidone and processes of preparation thereof |
| CA2936746C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| MX2018007977A (es) * | 2015-12-31 | 2018-11-09 | Cadila Healthcare Ltd | Forma farmaceutica osmotica de liberacion extendida que contiene una carga de clorhidrato de metilfenidato alta. |
| EP3501504A1 (en) | 2017-12-22 | 2019-06-26 | Pharmacia Polonica sp. z o.o. | Modified release tablet of paliperidone and a process for the preparation thereof |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US4842867A (en) * | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
| GB2206046B (en) * | 1987-06-25 | 1991-04-03 | Alza Corp | Multi-unit delivery system |
| US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
| US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
| US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
| US5017381A (en) * | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
| ES2149250T3 (es) * | 1993-04-23 | 2000-11-01 | Novartis Ag | Dispositivo para la administracion de medicamentos con liberacion controlada. |
| GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
-
1997
- 1997-08-08 ES ES97936421T patent/ES2194210T3/es not_active Expired - Lifetime
- 1997-08-08 PT PT97936421T patent/PT957899E/pt unknown
- 1997-08-08 DK DK97936421T patent/DK0957899T3/da active
- 1997-08-08 CN CN200910129895.8A patent/CN101518517B/zh not_active Expired - Lifetime
- 1997-08-08 CN CNB97197439XA patent/CN100484518C/zh not_active Expired - Lifetime
- 1997-08-08 AU AU39095/97A patent/AU3909597A/en not_active Abandoned
- 1997-08-08 AT AT97936421T patent/ATE234602T1/de active
- 1997-08-08 JP JP50984198A patent/JP4393587B2/ja not_active Expired - Lifetime
- 1997-08-08 DE DE69720055T patent/DE69720055T2/de not_active Expired - Lifetime
- 1997-08-08 EP EP97936421A patent/EP0957899B1/en not_active Expired - Lifetime
- 1997-08-08 WO PCT/US1997/013816 patent/WO1998006380A2/en not_active Ceased
- 1997-08-08 CA CA002263558A patent/CA2263558A1/en not_active Abandoned
- 1997-08-13 ZA ZA9707254A patent/ZA977254B/xx unknown
-
2004
- 2004-08-27 CY CY0400067A patent/CY2475B1/xx unknown